MRSA Clinical Trial
Official title:
Use of Disposable Stethoscope Covers for Reduction of Stethoscope MRSA Contamination
NCT number | NCT03601741 |
Other study ID # | 17-01633 |
Secondary ID | |
Status | Completed |
Phase | N/A |
First received | |
Last updated | |
Start date | June 8, 2018 |
Est. completion date | April 5, 2019 |
Verified date | September 2019 |
Source | NYU Langone Health |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
This is a prospective pilot study using a randomized, controlled, single blinded, crossover
trial design, evaluating the effect of daily antimicrobial stethoscope diaphragm covers
versus uncovered stethoscope. Stethoscopes will be cleaned Sani-cloth germicidal disposable
wipes which are effective against MRSA. Each participant will then be randomly assigned to 7
days in either the intervention or the control arm. At the end of the 7 days participants
stethoscopes will be cleaned again. This will be followed by another 7 days in the arm that
they are not in during the first 7 days.
The primary endpoint is MRSA colony count from stethoscope diaphragms cultures at 7 days,
focusing on the difference between the intervention and the control periods. The secondary
endpoint is the rate of hospital acquired MRSA infection in patients treated by residents
during each period.
Status | Completed |
Enrollment | 1 |
Est. completion date | April 5, 2019 |
Est. primary completion date | April 5, 2019 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | N/A and older |
Eligibility |
Inclusion Criteria: - Internal Medicine Residents Exclusion Criteria: - NA |
Country | Name | City | State |
---|---|---|---|
United States | New York University School of Medicine | New York | New York |
Lead Sponsor | Collaborator |
---|---|
NYU Langone Health |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | MRSA colony count cultured from stethoscope diaphragms | Total CFU of each selected pathogen at 7 days compared by paired Mann-Whitney U tests, with each patient serving as their own control | 7 Days | |
Secondary | Rate of hospital acquired MRSA infection in patients treated by participating residents | Rates on nosocomial infection in each arm compared through use of Kaplan Meier curves | 14 Days |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03181932 -
AeroVanc in the Treatment of Methicillin-resistant Staphylococcus Aureus Infection in Patients With Cystic Fibrosis
|
Phase 3 | |
Completed |
NCT03268122 -
Comparison of Standard Isolation With Targeted Isolation for Preventing Nosocomial Transmission of MRSA and VRE
|
N/A | |
Completed |
NCT04312776 -
Tracing MRSA in Households With Patients Infected With CA-MRSA by WGS
|
||
Recruiting |
NCT04104178 -
Optimal Treatment of MRSA Throat Carriers
|
Phase 3 | |
Recruiting |
NCT04793152 -
Vancomycin Dosing for Serious MRSA Infections: A Non-inferiority Randomized Trial of Trough Level Versus AUC/MIC
|
N/A | |
Completed |
NCT02690415 -
Community-Assoc. S. Aureus Colonization and Recurrent Infection in Pts With Uncomplicated S. Aureus Skin Abscesses
|
||
Enrolling by invitation |
NCT04297592 -
Antibiotic Prophylaxis in High-Risk Arthroplasty Patients
|
Phase 4 | |
Recruiting |
NCT05268120 -
MRSA Decolonization in Complicated Carriage
|
N/A | |
Completed |
NCT01167452 -
Effect of Weight and/or Obesity on Sulfamethoxazole and Trimethoprim Concentrations
|
Phase 4 | |
Recruiting |
NCT04083092 -
Surveillance of Community-Associated MRSA
|
||
Recruiting |
NCT02443064 -
Pharmacokinetics/ Pharmacodynamics (PK/PD) Study of Vancomycin
|
Phase 4 | |
Completed |
NCT02029872 -
Stop Community MRSA Colonization Among Patients
|
Phase 4 | |
Not yet recruiting |
NCT05696132 -
Evaluation of the Decolonization Rate and Acceptance of a Complete Nasal Decolonization Kit With Povidone Iodine for MRSA Patients
|
Phase 2 | |
Recruiting |
NCT02127658 -
MRSA Eradication and Decolonization in Children
|
N/A | |
Completed |
NCT00822276 -
The Underlying Mechanisms For S. Aureus Infection And Colonization Of Skin in People With Atopic Dermatitis With And Without Eczema Herpeticum (MRSA)
|
N/A | |
Withdrawn |
NCT02547116 -
Epidemiology and Treatment of Small-colony Variant Staphylococcus Aureus in Cystic Fibrosis
|
Phase 4 | |
Completed |
NCT01318213 -
Benefits of Universal Glove and Gowning
|
||
Completed |
NCT03304873 -
Retapamulin as a Decolonizing Agent for MRSA
|
Phase 3 | |
Enrolling by invitation |
NCT05395520 -
Vancomycin Monitoring: Is AUC Monitoring Appropriate for More Than Just Serious MRSA Infections?
|